| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6132758 | BAYER HEALTHCARE LLC | Stabilized antihistamine syrup |
Jun, 2018
(5 years ago) | |
Claritin is owned by Bayer Healthcare Llc.
Claritin contains Loratadine.
Claritin has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Claritin are:
- US6132758
Claritin was authorised for market use on 27 November, 2002.
Claritin is available in syrup;oral dosage forms.
The generics of Claritin are possible to be released after 01 June, 2018.
Drugs and Companies using LORATADINE ingredient
Market Authorisation Date: 27 November, 2002
Treatment: NA
Dosage: SYRUP;ORAL
How can I launch a generic of CLARITIN before it's drug patent expiration?
More Information on Dosage
CLARITIN family patents
